Evidence map›Paper›PMID 39670384›Full record

ArticlePacific Symposium on Biocomputing. Pacific Symposium on Biocomputing2025

Understanding TCR T cell knockout behavior using interpretable machine learning.

Marcus Blennemann, Archit Verma, Stefanie Bachl, Julia Carnevale, Barbara E Engelhardt

Abstract read
In one paragraph

Article in Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Marcus BlennemannGladstone Institutes, San Francisco, CA 94158, USA, marcus.blennemann@gladstone.ucsf.edu.
Archit VermaGladstone Institutes, San Francisco, CA 94158, USA, archit.verma@gladstone.ucsf.edu.
Stefanie BachlUniversity of California, San Francisco, San Francisco, CA 94143, USA, stefanie.bachl@ucsf.edu.
Julia CarnevaleUniversity of California, San Francisco, San Francisco, CA 94143, USA, julia.carnevale@ucsf.edu.
Barbara E EngelhardtGladstone Institutes, San Francisco, CA 94158, USA, bengelhardt@stanford.edu.

Funding

The Cellular Geography of Therapeutic Resistance in CancerU2CCA233195 · NCI · DANA-FARBER CANCER INST · PI JOHNSON, BRUCE E. · 2018 to 2023
$13.7M
A kinetic framework to map the genetic determinants of alternative RNA isoform expressionR01HG012967 · NHGRI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Barbara Engelhardt, Athma A Pai · 2023 to 2026
$3.0M
Methods to build and annotate tissue atlases using spatial genomic dataR01HG013736 · NHGRI · J. DAVID GLADSTONE INSTITUTES · PI Barbara Engelhardt · 2024 to 2026
$2.5M
Targeting SOCS1 and RASA2 to Engineer More Potent Adoptive T Cell Therapies for Cancer Treatment.K08CA252605 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CARNEVALE, JULIA C · 2020 to 2024
$1.3M
NCI NIH HHS K08 CA252605NCI NIH HHS U2C CA233195NHGRI NIH HHS R01 HG012967NHGRI NIH HHS R01 HG013736
6 · The paper itself

Abstract

Genetic perturbation of T cell receptor (TCR) T cells is a promising method to unlock better TCR T cell performance to create more powerful cancer immunotherapies, but understanding the changes to T cell behavior induced by genetic perturbations remains a challenge. Prior studies have evaluated the effect of different genetic modifications with cytokine production and metabolic activity assays. Live-cell imaging is an inexpensive and robust approach to capture TCR T cell responses to cancer. Most methods to quantify T cell responses in live-cell imaging data use simple approaches to count T cells and cancer cells across time, effectively quantifying how much space in the 2D well each cell type covers, leaving actionable information unexplored. In this study, we characterize changes in TCR T cell's interactions with cancer cells from live-cell imaging data using explainable artificial intelligence (AI). We train convolutional neural networks to distinguish behaviors in TCR T cell with CRISPR knock outs of CUL5, RASA2, and a safe harbor control knockout. We use explainable AI to identify specific interaction types that define different knock-out conditions. We find that T cell and cancer cell coverage is a strong marker of TCR T cell modification when comparing similar experimental time points, but differences in cell aggregation characterize CUL5KO and RASA2KO behavior across all time points. Our pipeline for discovery in live-cell imaging data can be used for characterizing complex behaviors in arbitrary live-cell imaging datasets, and we describe best practices for this goal.

Indexed as

Computational BiologyMachine LearningNeoplasmsReceptors, Antigen, T-CellT-LymphocytesCRISPR-Cas SystemsGene Knockout TechniquesHumansNeural Networks, ComputerReceptors, Antigen, T-Cell

Identifiers

PMID39670384
PMCPMC12456732

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.